Barr pulls application for generic Premarin
Executive Summary
Barr will withdraw its ANDA for a generic of Wyeth's Premarin (conjugated estrogens) after an appeals court affirmed a ruling against Barr's raw materials supplier. In a decision issued Jan. 24, a St. Louis, Mo. federal appeals court upheld a 2003 decision by a St. Paul, Minn. district court that found that Natural Biologics misappropriated trade secrets from Wyeth (1"The Pink Sheet" Oct. 13, 2003, p. 25)....
You may also be interested in...
Premarin Generics Reined In; Barr Supplier “Cannot Be Trusted,” Judge Says
Natural Biologics lacks the expertise to reproduce Wyeth's estrogen extraction process for conjugated estrogens (Premarin) by legitimate means, St. Paul, Minn. federal court Judge Joan Ericksen maintained in issuing a permanent injunction against the company
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.